FindTrial
Sign In

Efficacy of vamana karma and kuberaksha vati (tablet) in Polycystic ovarian syndrome

Randomized controlled clinical study to evaluate the effect of vamana karma followed by kuberaksha vati in the management of polycystic ovarian syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036174
Enrollment
75
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N830- Follicular cyst of ovary

Interventions

None listed

Sponsors

CSMSS ayurved college kanchanwadi aurangabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with PCOS Patient fit for vamana Patient of age 16-40 years irrespective of their marital status

Exclusion criteria

Exclusion criteria: Patient of age group less than 15 and more than 40 years Diagnosed cases of cervical tumor, polyp, uterine fibroid, endometriosis Patient showing signs and symptoms other than PCOS

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of vamana karma followed by kuberaksha vati in the management of irregualrity of menses in PCOS.Timepoint: 90 days with follow up on 30th 60th and 90th day—

Secondary

MeasureTime frame
To compare the effect of vamana karma followed by kuberaksha vati and kuberaksha vati in PCOS such as hirsutism acne obesity irregular menses and follicular growth To compare the effect of vamana karma followed by kuberaksha vati and vamana karma in PCOS such as hirsutism acne obesity irregular mesnses and follicular growth To study PCOS according to modern science To study the correlated disease to PCOS according to ayurvedaTimepoint: 90 days with follow up on 30th 60th and 90th day—

Countries

India

Contacts

Public ContactDr Darshani Navneet Kale

CSMSS ayurved college kanchanwadi aurangabad

dryennawar11@gmail.com9850562524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026